Navigation Links
Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
Date:8/3/2009

mely low.

Sumavel DosePro should not be used within 24 hours of other ergotamine-containing or ergot-type medications or other 5-HT1( )agonists and is not generally recommended for use with selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors SNRIs or MAO inhibitors. Sumavel DosePro should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

The most common adverse events observed in controlled clinical trials with sumatriptan injection were injection site reactions, atypical sensations (such as feelings of tingling, warm/hot sensations), dizziness and flushing. Most side effects lasted for only a short time. In clinical trials comparing the safety and tolerability of Sumavel DosePro to sumatriptan injection, most injection site reactions resolved spontaneously.

About DosePro technology

The DosePro technology is an easy-to-use, pre-filled drug delivery system designed to enable self-administration of single doses of liquid drug formulations, subcutaneously, without a needle. The DosePro technology has undergone more than ten years of design, process engineering, clinical evaluation and development work. DosePro is protected by more than 80 patents, issued and applied for, worldwide. Approximately 9,000 injections have been delivered in clinical trials in healthy volunteers using the DosePro needle-free drug delivery system.

About Zogenix

Zogenix, Inc., with offices in Emeryville and San Diego, Calif., is a privately held pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain. The company's initial focus is the commercialization of Sumavel DosePro. Zogenix submitted a New Drug Application with the U.S. Food and Drug Administration for Sumavel DosePro in December 2007, and received FDA approval in
'/>"/>

SOURCE Astellas Pharma US, Inc.; Zogenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. FDA Approves Additional Indication for Astellas MYCAMINE(R)
3. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
4. Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
5. Astellas Announces New Vice President of Marketing
6. Astellas Hires New Vice President of Compliance
7. Astellas Adds CNS Therapy Area Leader to Global R&D Team
8. Astellas Names Head of Global R&D Operations
9. NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
10. AUA Foundation names the 2009 Astellas Rising Stars in Urology award winners
11. Scientists Spot Brains Free Will Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... 31, 2015 , ... Three Bakers Gluten Free Bakery launched the redesign of ... and easy-to-find information on their offering of gluten-free breads and pizzas, living without gluten, ... way for us to share information about our gluten free product offerings, but also ...
(Date:8/31/2015)... MN (PRWEB) , ... August 31, 2015 , ... ... new product introductions: The Terrace Outdoor Sauna. After months of extensive engineering and design ... sauna model built to withstand the elements and is offered at a very attractive ...
(Date:8/31/2015)... ... August 31, 2015 , ... DR. LUCIANA ... Lagana (aka Dr. Luciana) received a total of three Silver Medal awards ... and Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this pilot with Del ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... accessible primary care, is enhancing its existing presence in Tennessee with the opening ... location is the company’s second in Knoxville, sixteenth in Tennessee, and 148th in ...
(Date:8/31/2015)... ... August 31, 2015 , ... The more hours young adults spend ... mass index and bigger waist circumference, a 15-year analysis by the University of Pittsburgh ... in later years, indicating that young adulthood is an important time to intervene and ...
Breaking Medicine News(10 mins):Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3
... team up to make food fun,for those with diabetes, ... the daily decisions they make about food can have ... (ADA), together,with The HealthCentral Network,s FoodFit.com, launched Diabetes Foodsmart,today, ... to food for those,with diabetes., Based on the ...
... with 20 percent of all lung malignancies, scientists say ... appear to work together are associated with 20 percent of ... lung development, researchers report. , Understanding how these genes mesh ... according to the report in this week,s issue of the ...
... IRVINE, Calif., Oct. 9 Spectrum,Pharmaceuticals, Inc., (Nasdaq: ... of the Company on Wednesday, October 10, 2007, at ... at the Palace Hotel in San,Francisco, California. Spectrum,s presentation ... live webcast of Spectrum,s presentation will be available at, ...
... Two of the three scientists receiving the 2007 Nobel Prize ... Society early in their careers, bringing to 42 the number ... grantees Mario R. Capecchi, Ph.D. of the University of Utah ... are co-winners along with Sir Martin J. Evans of Cardiff ...
... Oct. 9 In light of last week,s,controversy ... seafood for,pregnant women and the announcement from private ... least 12 ounces of fish,and seafood a week, ... in the natural products sector, suggests that private ...
... Roaming Across ... Campuses in North Carolina, RESTON, Virginia, October 9 ... (RTLS), today announced,that it has been selected as the RTLS vendor ... system in the,United States. CHS is using the Ekahau RTLS solution ...
Cached Medicine News:Health News:Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter 2Health News:Healthy Living Made Easy with New Diabetes Foodsmart e-Newsletter 3Health News:3 New Lung Cancer Genes Identified 2Health News:Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum 2Health News:Purified Fish Oil Concentrates Offer Solution to Current Seafood Controversy for Pregnant and Breastfeeding Women! 2Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 2Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 3Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 4
(Date:8/31/2015)... Vascular Ltd., together with its subsidiaries (the "Company" ... the "Group"), a global company engaged in the ... for the minimally invasive treatment of vascular disease, ... ("BTK") cohort of patients in the Chocolate® Balloon ... 15, 2015 at the 5th Annual Amputation Prevention ...
(Date:8/30/2015)... -- Noser Health and Netcetera ... deliver new platform   ... transaction platform, announced today strategic partnerships with Noser ... bring to market its global health data transaction platform. ... business model is built on trust, neutrality, impact and ...
(Date:8/28/2015)... 28, 2015  Delays in the launch and ... down the decision-making process, resulting in missed opportunities ... for biopharmaceutical companies to develop a tactical approach ... quicker and more meaningful insights. ... nearly three-quarters of benchmarked study participants use review ...
Breaking Medicine Technology:Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4Expediting the Pharmaceutical Market Research Process for Faster Insights 2
... ViroPharma Incorporated (Nasdaq: VPHM ) today ... Centralized Marketing Authorization for Cinryze® (C1 inhibitor [human]) ... for routine prevention, pre-procedure prevention and acute treatment ... self administration option for appropriately trained patients included ...
... Texas, June 15, 2011 Two clinical trial studies authored by ... United Network of US Oncology have been selected to be ... July 29-30 in Miami and August 5-6 in Seattle. ... its 47th Annual Meeting June 3-7 at McCormick Place in Chicago. ...
Cached Medicine Technology:ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 2ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 3ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 4ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 5ViroPharma's Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE) 6Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians 2Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians 3Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians 4
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The electrically active helix of CapSureFix Novus lead is designed to extend easily for active fixation and retract for venous passage....
Steroid eluting pacemaker leads...
... family of temporary sensing and pacing leads. ... in temporary pacing leads and improved upon ... use and less traumatic to heart tissue. ... Pacing Lead is designed for temporary atrial ...
Medicine Products: